|
In late 2019, the SARS-COV-2 pandemic posed a serious threat to human health and social-economic development. Looking back to human history, several kinds of infectious diseases, such as smallpox, plague, and Spanish flu, all made huge impacts on human society. Until now, influenza virus, rabies virus, respiratory syncytial virus, human papillomavirus and many other infectious viruses are still constantly threatening the safety of our life. Therefore, now current scientific and medical industry is focusing to develop safe and effective vaccines and drugs to prevent and treat infectious diseases.
ACROBiosystems has accumulated mature technology and experience in viruses and vaccines. Since the COVID-19 outbreak, we continued to develop core reagents for other infectious virus research, vaccine, and therapeutic drug development based on its high-quality platform. We will continue to monitor the development of infectious diseases worldwide, aiming to provide core reagents for accelerating the development and clinical trials of vaccines and therapeutic drugs.
|
